Market revenue in 2023 | USD 114.5 million |
Market revenue in 2030 | USD 255.2 million |
Growth rate | 12.1% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 53.28% in 2023. Horizon Databook has segmented the Russia neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
Rising number of people suffering obesity and increasing geriatric population is expected to fuel market growth in Russia. Growing prevalence of obesity in adult population aged 25–65 years is boosting the demand for neurostimulation devices in the country.
According to WHO estimates, about 60% of the Russian population is overweight, and nearly 20% is suffering from obesity, owing to factors such as high consumption of junk food and increasing adoption of sedentary lifestyles. Thus, the abovementioned factors are likely to contribute to market growth in Russia during the forecast period.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account